C12N 2501/52
Cd40, cd40-ligand
Official title: CD40, CD40-ligand (CD154)
C12N2501/52 (Cd40, cd40-ligand) appears on 83 US grants and 172 published applications in this corpus.
Search patents in C12N- Granted patents
- 83
- Published applications
- 172
- Assignees
- 109
- Inventors
- 357
- Latest grant
- 5 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 1 |
| 2002 | 2 | 6 |
| 2003 | 1 | 3 |
| 2004 | 0 | 8 |
| 2005 | 1 | 6 |
| 2006 | 0 | 5 |
| 2007 | 1 | 4 |
| 2008 | 1 | 3 |
| 2009 | 2 | 5 |
| 2010 | 2 | 10 |
| 2011 | 2 | 5 |
| 2012 | 8 | 8 |
| 2013 | 5 | 1 |
| 2014 | 4 | 6 |
| 2015 | 2 | 4 |
| 2016 | 4 | 4 |
| 2017 | 5 | 9 |
| 2018 | 4 | 8 |
| 2019 | 7 | 8 |
| 2020 | 6 | 13 |
| 2021 | 2 | 16 |
| 2022 | 3 | 10 |
| 2023 | 5 | 6 |
| 2024 | 5 | 11 |
| 2025 | 4 | 7 |
| 2026 | 3 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Genetic engineering of B cell receptors and uses thereof in antigen-induced antibody secretion5 May 2026US 12,617,832 B2Ramot at Tel-Aviv University Ltd.
- Constructs for chimeric antigen receptors14 Apr 2026US 12,600,796 B2Carisma Therapeutics Inc.
- Methods for selection and stimulation of cells and apparatus for same13 Jan 2026US 12,522,660 B2C3S2 GmbH
- Composition for culturing peripheral blood monocyte-derived regulatory t cell and regulatory T cell culturing method using same18 Nov 2025US 12,473,534 B2Immunisbio Co., Ltd.
- Dendritic cell preparation and preparation method thereof14 Oct 2025US 12,440,565 B1Zsky Biotech Inc.
- Genetic engneering of b cell receptors and uses thereof in antigen-induced antibody secretion17 Sep 2026US 2026/0274916 A1Ramot at Tel-Aviv University Ltd.
- Methods for the production of dendritic cells by modulating retinoid signaling6 Aug 2026US 2026/0226411 A1FUJIFILM Holdings America Corporation
- In vitro cultivation method for antibody expressing cells16 Jul 2026US 2026/0201327 A1Roche Diagnostics Operations, Inc.
- Maturation of dendritic cells30 Apr 2026US 2026/0115227 A1Bioclones Proprietary Limited
- Monoclonal antibody isolation26 Feb 2026US 2026/0055165 A1Imperial College Innovations Limited
Most cited
By later US patents
- Binding domain-immunoglobulin fusion proteins96US 7,754,208 B2Trubion Pharmaceuticals, Inc. · 2010
- Activated dendritic cells and methods for their activation54US 6,017,527 AImmunex Corporation · 2000
- Method of stimulating an immune response with activated dendritic cells52US 6,497,876 B1Immunex Corporation · 2002
- Method of inducing memory B cell development and terminal differentiation33US 7,378,276 B2The United States of America as represented by the Department of Health and Human Services · 2008
- Dendritic cells; methods32US 6,660,523 B2Schering Corporation · 2003